Home › Funds › Two Sigma Investments › LBRX
Two Sigma Investments position in LBRX
LB PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)48.65K sh
Reported value held$1.58M
Portfolio Weight0.00%
First reportedQ3 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 13.50K | $213.16K | New |
| Q4 2025 | 12.72K | $283.15K | Reduce |
| Q1 2026 | 12.72K | $313.68K | Hold |
| Q2 2026 | 48.65K | $1.58M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LBRX
- BlackRock Inc 2.73M sh · $88.74M · Q2 2026
- JPMorgan Chase & Co 1.50M sh · $48.87M · Q2 2026
- Balyasny Asset Management 921.47K sh · $29.91M · Q2 2026
- Vanguard Group 1.11M sh · $24.77M · Q4 2025
- Geode Capital Management 612.79K sh · $19.89M · Q2 2026
- Goldman Sachs Group 576.46K sh · $18.71M · Q2 2026
- Millennium Management 259.22K sh · $8.41M · Q2 2026
- Citadel Advisors 215.97K sh · $7.01M · Q2 2026
- Charles Schwab Investment Management 195.49K sh · $6.34M · Q2 2026
- Fidelity Management & Research (FMR) 188.91K sh · $6.13M · Q2 2026
- Northern Trust Corp 186.04K sh · $6.04M · Q2 2026
- UBS Group AG 85.95K sh · $2.79M · Q2 2026